A number of people may have a natural immunity to the Cas9 proteins of the CRISPR-Cas9 genome editing machinery, Stat News reports. This, Fierce Biotech adds, could complicate efforts to develop the tool as a therapeutic approach.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.